Crossmark

Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Crossref DOI link: https://doi.org/10.1007/s13311-018-0668-6

Published Print: 2018-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ovsepian, Saak Victor

O'Leary, Valerie Bríd
License Information

Text and Data Mining valid from 2018-10-01

Text and Data Mining valid from 2018-10-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-018-0668-6

Content Type: article

Copyright: Copyright © 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.